|
|
|
This is the preliminary program for the 2008 Joint Statistical
Meetings in Denver, Colorado.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2008 Program page |
= Applied Session,
= Theme Session,
= Presenter|
|
||
148
|
Mon, 8/4/08, 10:30 AM - 12:20 PM | CC-607 |
| Early Human Trials and Crossover Designs - Contributed - Papers | ||
|
Biopharmaceutical Section, Biometrics Section |
||
| Chair(s): Stephanie Dunbar, Merck Research Laboratories | ||
| 10:35 AM |
Statistical Issues for First-in-Human Designs —  Xiaoni Liu, Bristol-Myers Squibb Company; Robert Smith, Bristol-Myers Squibb Company
|
|
| 10:50 AM |
Linear Models for the Analysis of Alternating Panel Rising Dose Designs — Bo Jin, Merck & Co., Inc.; Peng Sun, Merck & Co., Inc.
|
|
| 11:05 AM |
Statistical Analysis Methods and Clinical Pharmacology Understanding on Bioavailability Comparison in Complete and Incomplete Crossover Design and Parallel Design Studies — Yonghua Wang, Bristol-Myers Squibb Company
|
|
| 11:20 AM |
The Influence of Time on Individual Effect Variability in a Two-Treatment, Three-Periods Crossover Design — Edwin Ndum, Kansas State University; Gary L. Gadbury, Kansas State University
|
|
| 11:35 AM |
Use of Baseline Measurements in the 2 X 2 Crossover Trial — Lingling Han, Merck & Co., Inc.; John Stufken, The University of Georgia
|
|
| 11:50 AM | Floor Discussion | |
|
JSM 2008
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |